37 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
reliance upon, the information we provide. If we cannot successfully defend ourselves against claims that our products caused injuries, we may incur
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
of, or inappropriate reliance upon, the information we provide. If we cannot successfully defend ourselves against claims that our products caused injuries, we may
424B5
SLNO
Soleno Therapeutics Inc
30 Mar 22
Prospectus supplement for primary offering
5:21pm
successfully defend ourselves against claims that our products caused injuries, we may incur substantial liabilities. Regardless of merit or eventual
424B5
5esjjd8p3ltpkwm
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
4tg9r28aexihq3ao4pc
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
jkf72 vp35p
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
h0ist6
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
ha7w8finjhu zgxfx5h
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
rjuum5d6
12 Apr 19
Prospectus supplement
4:41pm